Laura Ridolfi

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine · 2011 · 531 citations · Full text

Medicine, Immunology, Oncology +17

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy

Riccardo Danielli, Ruggero Ridolfi, Vanna Chiarion‐Sileni et al. · Cancer Immunology Immunotherapy · 2011 · 133 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Ruggero Ridolfi, Angela Riccobon, Riccardo Galassi et al. · Journal of Translational Medicine · 2004 · 119 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Paola Queirolo, Francesco Spagnolo, Paolo A. Ascierto et al. · Journal of Neuro-Oncology · 2014 · 119 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

Giuseppe Procopio, Elena Verzoni, Sergio Bracarda et al. · British Journal of Cancer · 2011 · 71 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15